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Purpose: The advent of endovascular prostheses to treat descending thoracic aortic lesions offers an alternative approach
in patients who are poor candidates for surgery. The development of this approach includes complications that are
common to the endovascular treatment of abdominal aortic aneurysms and some that are unique to thoracic
endografting.
Methods: We conducted a retrospective review of 60 emergent and high-risk patients with thoracic aortic aneurysms
(TAAs) and dissections treated with endovascular prostheses over 4 years under existing investigational protocols or on
an emergent compassionate use basis.
Results: Fifty-nine of the 60 patients received treatment, with one access failure. Thirty-five patients received treatment of
TAAs. Four of these procedures were performed emergently because of active hemorrhage. Twenty-four patients with
aortic dissections (16 acute, 8 chronic) also received treatment. Eight of the patients with acute dissection had active
hemorrhage at the time of treatment. Three devices were used: AneuRx (Medtronic; n 31), Talent (Medtronic; n 27),
and Excluder (Gore; n  1). Nineteen secondary endovascular procedures were performed in 14 patients. Most were
secondary to endoleak (14 of 19), most commonly caused by modular separation of overlapping devices (n  8). Other
endoleaks included 4 proximal or distal type I leaks and 2 undefined endoleaks. The remaining secondary procedures were
performed to treat recurrent dissection (n  1), pseudoaneurysm enlargement (n  3), and endovascular abdominal
aortic aneurysm repair (n  1). One patient underwent surgical repair of a retrograde ascending aortic dissection after
endograft placement. Procedure-related mortality was 17% in the TAA group and 13% in the dissection group, including
2 acute retrograde dissections that resulted in death from cardiac tamponade. Overall mortality was 28% at 2-year
follow-up.
Conclusion: Although significant morbidity and mortality remain, endovascular repair of descending TAAs and dissec-
tions in patients at high-risk patients can be accomplished with acceptable outcomes compared with traditional open
repair. The major cause for repeat intervention in these patients was endoleak, most commonly caused by device
separation. Improved understanding of these complications may result in a decrease in secondary procedures, morbidity,
and mortality in these patients. The need for secondary interventions in a significant number of patients underscores the
necessity for continued surveillance. (J Vasc Surg 2004;40:228-34.)The successful development of endovascular prostheses
for treatment of abdominal aortic aneurysms (AAA) has led
to concomitant use of this technology for treatment of
thoracic aortic disease. Because the morbidity and mortality
associated with open surgical repair of thoracic lesions is
high, the advantages of an endovascular approach to tho-
racic aortic aneurysms (TAAs) and dissections may exceed
those of endovascular treatment of AAAs.1-3 In addition,
the advent of endovascular prostheses to treat descending
thoracic aortic lesions offers an alterative approach in pa-
tients who are poor surgical candidates.
Several authors have reported early initial success with
endografting of thoracic aortic lesions.4-9 Like endovascu-
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doi:10.1016/j.jvs.2004.03.051228lar treatment of AAAs, however, endoluminal treatment of
TAAs and dissections is not without complications. This
report describes a continuing single-center experience with
endovascular management of thoracic aortic disease, in-
cluding TAAs and dissections, with a variety of endovascu-
lar devices.
METHODS
The objective of the study was to analyze the single-
center experience with endovascular treatment of thoracic
aortic disease, including both emergent and elective TAAs,
and acute and chronic thoracic dissection, with a combina-
tion of stent-graft systems. Patients received either AneuRx
(Medtronic AVE), Talent (Medtronic AVE), and Excluder
(W. L. Gore) thoracic devices over 4 years from October
1998 to January 2003. All patients were entered into a
protocol approved by the institutional review board at our
institution, and signed consent forms for the investigational
devices and surveillance protocols used to generate the data
reported. The inclusion and exclusion criteria for patients
in the initial AneuRx investigational device exemption
(IDE) have been detailed,5 and the later patients (Talent,
Excluder) received treatment as part of an investigator IDE
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reported as emergency use. An outline of indications in
each subgroup is presented below. Prophylactic use of
cerebrospinal fluid (CSF) drainage or other adjunctive ther-
apy to prevent spinal cord ischemia was not routinely used.
However, CSF drainage was used subsequent to develop-
ment of lower extremity paresis.
Indications. Indications for treatment of TAAs in-
cluded diameter greater than 5 cm; aneurysm diameter 4 to
5 cm, with an increase of more than 0.5 cm over 6 months;
or saccular aneurysm or penetrating ulcer. Only patients
with descending thoracic aortic dissection (Stanford type
B) were considered candidates for treatment. Specific indi-
cations for treatment of thoracic dissection were acute
dissection with intractable pain, uncontrollable hyperten-
sion, progression of dissection, or end-organ ischemia;
chronic dissection with aneurysm dilatation of the proximal
descending aorta; or chronic dissection with acute
symptoms.
Thoracic devices. The AneuRx thoracic device, a self-
expanding device, is constructed of polyethylene tereph-
thalate fabric and nitinol stents, and is 23F in outer diam-
eter. The thoracic devices are supplied in 6-cm and 12-cm
long modular components, with stent-graft diameters of
32, 36, and 40 mm.5 The Talent thoracic devices are also
constructed of self-expanding nitinol stents. They vary in
length, width, and configuration, and can be customized
with a maximum stent-graft diameter of 46 mm and max-
imum device size of 25F. Devices with exposed proximal or
distal stents or “open-web” design are available.8 The
Excluder also uses a self-expanding nitinol framework,
which is combined with an expandable polytetrafluroethyl-
ene graft.9 This was used in 1 patient on compassionate use
basis. The devices used were 40 or 34 mm in diameter,
15-cm or 20-cm long, and 22F or 24F outer diameter.
When multiple devices were used a complete overlap of at
least 2 cm was used, with more overlap for severely angu-
lated segments. Stent diameters were oversized at 10% to
20% compared with the diameter of the aorta at the fixation
sites in aneurysms or 10% to 20% of the estimated adjacent
proximal aorta in dissections.
Deployment. Both TAAs and dissections were ap-
proached similarly. Catheter access was obtained through
unilateral or bilateral groin incisions after isolating the
common femoral arteries. Generally a 0.025-inch guide
wire was then passed through the entire length of the
thoracoabdominal aorta, and intravascular ultrasound
(IVUS) interrogation was performed with an 8.2-MHz
catheter (Jomed) to define diameter and length of the
proximal and distal landing zones. Proximal neck length
was defined as the distance from the descending aorta just
distal to the left subclavian artery to the origin of the
aneurysm or dissection.
In dissections, the wire was passed with frequent inter-
val IVUS imaging to ensure proper position of the wire in
the true lumen of the aorta. Once proper position was
confirmed, angiography was performed to define aortic
branch vessel anatomy. Devices were then positioned withconfirmatory angiography before deployment, to enable
precise positioning. In patients with short proximal necks a
5F pigtail catheter was percutaneously introduced from the
right upper extremity, usually the radial artery, passed
through the innominate artery, and positioned in the aortic
arch, to aid in identification of the origin of the left carotid
artery. Once deployed, endografts were assessed with a
combination of angiography and IVUS to identify the
presence of endoleak and evaluate the degree of device
apposition.
Clinical data. Patient data including demographic in-
formation, preexisting comorbid conditions, clinical symp-
toms, procedure details, postoperative complications, sec-
ondary procedures, and mortality were prospectively
collected as part of Food and Drug Administration–ap-
proved trials, as part of an investigator IDE, or treatment as
emergency use. Patients were classified on the basis of the
primary aortic disease, that is, TAA or dissection. Patients
were screened preoperatively with computed tomography
(CT), and followed up post-procedure with CT at 1 and 6
months, then yearly, to assess the success of aneurysm
exclusion and to observe the morphologic characteristics of
the aneurysms. Additional scans were obtained as needed to
address specific device or anatomic considerations. The
protocol consisted of helical or spiral mode CT with section
reconstruction at 2 or 3 mm, collimation 5, and pitch 1:1.5.
The CT angiograms were reconstructed in an interactive
environment (Medical Media Systems). Maximum aortic
diameters were obtained from centerline images.
RESULTS
Fifty-nine of 60 patients received treatment, with 1
access failure. Patient age ranged from 38 to 92 years
(mean, 72 years). Lesions were American Society of Anes-
thesiologists grade II to V (mean, grade IV). The average
maximum aortic diameter in patients with TAAs was 65
mm (range, 40-100 mm). Demographic comparisons be-
tween patients with TAAs and dissections are shown in
Table I, and demographic comparisons between TAA and
dissection subgroups are shown in Table II.
Thirty-five patients underwent treatment of TAAs.
Specific primary indications for treatment are shown in
Table III. Most TAAs were treated because of size or rapid
expansion. Other elective indications included penetrating
ulcers or saccular aneurysms. Four patients received emer-
gent treatment because of active extravasation from the
causes listed. Twenty-four patients received treatment of
thoracic dissections. Specific treatment indications are
shown in Table IV. In patients with chronic dissections,
indications included increasing size of concomitant pseu-
doaneurysm and failure of medical therapy to control re-
current chest pain or hypertension. In patients with acute
dissections, indications included enlarging pseudoaneu-
rysm, failure of medical therapy to control pain or hyper-
tension, and active extravasation with hemothorax or he-
moptosis. One patient received treatment of a traumatic
thoracic aortic dissection secondary to a motor vehicle
accident.
ts.
logists
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patients (98.3%). Three thoracic devices were used:
AneuRx (n  31), Talent (n  27), and Excluder (n  1).
Most procedures (66%) were performed with the patient
under local anesthetic supplemented by intravenously ad-
ministered hypnotic and analgesic agents as needed.10 The
mean duration of the procedure was 197 minutes (range,
38-530 minutes). Median blood loss was 500 mL (range,
100-7500 mL; mean, 1066 mL). In most patients blood
was captured in an autotransfusion canister and reinfused.
Twelve patients (20%) required on average 0.5 units
(range, 1-6 units) of additional blood transfusion. Patients
were routinely admitted to the surgical intensive care unit
postoperatively, with a median length of stay of 2 days
(range, 1-33 days), followed by a median total length of
stay of 7 days (range, 1-36 days).
Table I. Patient characteristics
TAA
Mean
Age (y) 73
ASA classification IV
Maximum aortic diameter (cm) 6.5
Proximal neck length (cm) 5.0
n
Emergent 4
Symptomatic 10
TAA, Thoracic aortic aneurysm; ASA, American Society of Anesthesiologis
Table II. Patient characteristics
TAA emergent
(N  4)
TAA
(N 
Mean Range Mean
Age (y) 72 62-83 73
ASA classification IV IV
Maximum aortic
diameter (cm)
6.8 6-7 6.5
Proximal neck
length (cm)
2.2 2-2.3 5.0
TAA, Thoracic aortic aneurysm; ASA, American Association of Anesthesio
Table III. Primary treatment indications for thoracic
aortic aneurysm
Emergent
(N  4)
Elective
(N  31)
Size (5 cm or rapidly expanding) 21
Penetrating ulcer 4
Saccular aneurysm 6
Extravasation
Acute perforation 2
Perioperative hemorrhage 1
Bronchial-aortic fistula 1Procedure-related mortality was 17% (n  6) in the
TAA group and 13% (n  3) in the dissection group.
Subgroup analysis of the TAA group revealed that 6 pa-
tients who underwent elective treatment sustained all of the
perioperative mortality (19% vs 0%), whereas all 4 patients
who underwent emergent procedures initially survived (Ta-
ble V). Most of the procedure-related mortality in the TAA
group was a result of perioperative myocardial infarction
(MI; n  3); 1 patient each died of intraoperative cardiac
arrest, massive embolization, and multisystem organ fail-
ure.
Subgroup analysis of patients with dissections revealed
that 2 patients in the acute group and 1 patient in the
chronic group died, resulting in an identical perioperative
mortality of 13% (Table V). One patient died of rupture
due to endoleak. Two others died of retrograde dissection
35) Dissection (N  24)
Range Mean Range
38-92 69 43-86
II-IV IV III-V
4-10 5 2-10
0.5-10 3.0 0-10
% n %
11 9 38
29 19 80
e Dissection acute
(N  16)
Dissection chronic
(N  8)
ange Mean Range Mean Range
8-92 70 51-86 68 43-83
II-IV IV III-IV IV III-IV
4-10 5 3-10 5 2-7
1-10 3 0-10 4 3-8
.
Table IV. Primary treatment indications for thoracic
dissection
Acute
(N  16)
Chronic
(N  8)
Pseudoaneurysm (5 cm or rapidly
expanding)
4 6
Failure of medical therapy 4 2
Extravasation
Hemothorax 6
Hemoptosis 1
Traumatic aortic dissection 1(N electiv
31)
R
3
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complication was observed in 1 additional patient in the
dissection group (discussed below), who ultimately under-
went surgical conversion.
At average follow-up of 2 years, combined overall mor-
tality for both groups was 28% (37% for TAA, 17% for
dissection). With regard to TAAs, overall mortality for the
emergent and elective groups was 35% and 50%, respec-
tively. Of the 4 patients in the emergent group 2 later died,
of MI and metastatic breast cancer, respectively. Five addi-
tional patients in the elective TAA group died at a mean of
9 months after treatment, for an overall mortality rate of
35%. Cause of death in three of these patients was cardiac
secondary to coronary bypass, hepatic failure secondary to
acute hepatitis A, and mesenteric thrombosis, respectively;
2 patients died of unknown causes. There was 1 late death
in the acute dissection group, contributing to an overall
mortality of 19% in that group. There were no late deaths in
the chronic dissection group, in which the overall mortality
rate remained at 13%.
Successful treatment of dissection was indicated by
relief of pain, and sealing of acute perforations with control
of hemorrhage and thrombosis of the false lumen. All
patients who underwent treatment of dissection underwent
thrombosis of the false lumen within the 1-month follow-
up. One patient had recurrent proximal dissection within 2
months, and underwent placement of a proximal cuff.
Proximal dilatation occurred in 3 patients who underwent
treatment of dissections resulting in expanding proximal
pseudoaneurysms. Because of concern about the potential
for endoleak formation and rupture, additional proximal
devices were deployed in each.
Two patients (3%) underwent surgical conversion. One
patient who was being treated for a traumatic thoracic
aortic dissection underwent immediate surgical conversion
because of failure of the device to deploy correctly and
exacerbation of the dissection with concern for rupture.
One patient underwent surgical conversion with ascending
arch repair after initial successful deployment of thoracic
endografts to treat thoracic dissection, which resulted in
subsequent development of a retrograde ascending aortic
dissection. Both patients survived and were eventually dis-
charged. Cumulative postoperative complications are listed
in Table VI. The most common complication was arrhyth-
mia (n  6), followed by pleural effusion (n  4), acute
renal insufficiency, defined as a transient elevation in creat-
inine concentration to greater than 1.5 (n 4), and urinary
tract infection (n 4). Three patients had acute ascending
thoracic dissections. Paraplegia occurred in 1 patient (2%)
Table V. Mortality
TAA
emergent
Perioperative (30 d) (%) 0
Overall (%) 50
TAA, Thoracic aortic aneurysm.successfully treated for TAA but in whom lower extremity
paralysis subsequently developed approximately 18 hours
post-procedure. The rate of all major and minor complica-
tions was 59%, and the rate of major complications was 25%.
Nineteen secondary procedures were performed in 14
patients (24%). Indications for secondary intervention are
listed in Table VII. The average time from initial procedure
to secondary intervention was 12 months. Most of these
procedures (14 of 19) were performed to treat endoleak,
most commonly caused by the modular separation of over-
lapping devices (n 8). Three patients underwent second-
ary procedures because of proximal pseudoaneurysm en-
largement. One patient was treated for recurrent dissection.
One patient underwent subsequent endovascular repair of
AAA.
In addition to endoleaks caused by device separation, 4
type I leaks also occurred (3 distal type I in the TAA group,
1 proximal type I in the dissection group). These patients
were treated expeditiously to prevent potential rupture.
Two other unidentified leaks occurred in the TAA group.
Although the origin of these leaks could not be identified,
because there was evidence of aneurysm sac perfusion these
were also treated without delay. No type II endoleaks were
identified in either group. No endoleaks were identified in
the chronic dissection subgroup. In addition, no difference
in endoleak with regard to device type was identified.
Four patients in this study had short proximal neck
lengths of 1 cm or less distal to the left subclavian artery. To
achieve acceptable proximal fixation (2 cm) in these
patients endografts were deployed immediately distal to the
left carotid artery, resulting in exclusion of the ostium of
the left subclavian artery from the aortic arch. None of these
patients underwent prophylactic left subclavian bypass.
There were no complications resulting from occlusion of
the ostium.
DISCUSSION
Open repair of thoracic aortic lesions entails an appre-
ciable mortality rate even among patients who are thought
to be reasonable candidates for repair. A recent study has
reported mortality rates for elective open TAA repair of 8%.
Patients operated on emergently do much worse. The same
study reports mortality rates for these patients at 57%.11
Najibi et al12 showed that elective endovascular repair of
TAA can be accomplished with similar mortality, shorter
intensive care unit stay, and less blood loss compared with
historical controls.
This study represents a single-center experience with
treating emergent and high-risk patients with TAA and
TAA
elective
Dissection
acute
Dissection
chronic
19 13 13
35 19 13
rdial in
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are not possible in this study, it is worth noting that even
among a patient population deemed at high-risk or ineligi-
ble for open repair because of preexisting comorbid condi-
tions, combined perioperative mortality was 15%. Overall
mortality was 28% with a mean follow-up of 2 years. These
results are similar to previous reports of procedure-related
mortality in patients undergoing endovascular treatment of
TAA and dissections.4,6-8
Although the patient population in this study was at
high risk, the combined minor and major morbidity rate
(60%) was similar to results of electively performed open
repair. In addition, the cumulative rate of pulmonary events
(17%), renal insufficiency (10%), and paraplegia (2%) com-
pare favorably with previous results from series of elective
open repair.
Table VI. Cumulative postoperative complications
Complication
TAA
emergent
T
ele
Cardiac
Arrhythmia 1
CHF
Q-wave MI
Non-Q-wave MI
Cardiac arrest
Tamponade
Vascular
Ascending thoracic
dissection
Pulmonary
Pleural effusion 1
Intubation 24 hr 1
ARDS
Pneumonia
Pulmonary edema
Renal
Acute renal insufficiency
Acute renal failure 1
Stroke
Paraplegia
Urinary tract infection
TAA, Thoracic aortic aneurysm; CHF, congestive heart failure; MI, myoca
Table VII. Indications for secondary procedure
Indication
TAA
emergent
TAA
elective
Endoleak
Device separation 0 5
Proximal leak 0 0
Distal leak 0 3
Undefined leak 0 2
Enlargement
Proximal 0 0
Distal 0 0
Recurrent dissection NA NA
AAA 0 0
TAA, Thoracic aortic aneurysm; AAA, abdominal aortic aneurysm; NA, noWith regard to cardiac complications, we previously
reported an incidence of (20%) for endovascular treatment
of TAAs and dissections.13 This rate is similar to that
reported for open TAA repair, and is congruent with pre-
vious reports in which the cardiac event rate for AAA was
similar for open and endovascular approaches.14,15 These
similarities suggest that cardiac complications may be a
function of the anesthetic or other surgical factors, such as
the inflammatory response, rather than the operative pro-
cedure itself. Because minor cardiac complications are in-
cluded, primarily transient postoperative arrhythmias and
non-Q-wave MI, the rate of cardiac complications in this
study is higher than that previously reported for endovas-
cular treatment of thoracic lesions.7-9 When cardiac events
are limited to Q-wave MI, the cardiac complication rate
decreases to 5%, which is in line with previous reports.
Dissection
acute
Dissection
chronic Overall
2 6
2 3
3
2
1 1 2
1 1 2
1 2 3
2 4
2
1 2
1
1
1 1 4
2
1 2
1
2 1 4
farction; ARDS, acute respiratory distress syndrome.
Dissection
acute
Dissection
chronic
Overall
(N  19)
3 0 8
1 0 1
0 0 3
0 0 2
2 1 3
0 0 0
1 0 1
0 1 1
lable.AA
ctive
3
1
3
1
1
1
1
1
2
1
1
1
1t avai
JOURNAL OF VASCULAR SURGERY
Volume 40, Number 2 Hansen et al 233Although not sufficiently powered to provide statistical
comparison between subgroups, it is interesting to note
that patients with TAA who required emergent treatment
had the lowest procedure related mortality (0%), although
all had active bleeding at presentation. In addition, proce-
dure-related mortality in patients with dissections was iden-
tical (13%) between the acute and chronic groups, even
though the primary indication for treatment in half of the
acute group was active bleeding and none of the patients in
the chronic group had active bleeding. These results sug-
gest that, even among patients with the highest risk, endo-
vascular repair can be undertaken with acceptable mortal-
ity. Given the high mortality in patients who undergo
emergent open repair, these patients would seem to benefit
most from endovascular treatment.
Most secondary interventions in this study were per-
formed to treat endoleak, which was most commonly the
result of modular device separation. Device separation was
the leading cause of secondary intervention in both the
TAA and dissection groups. Of interest, device separation
was not a problem in the chronic dissection subgroup. The
precise mechanism for development of this complication is
unknown, but is likely due in part to thoracic aortic remod-
eling. As the thoracic aorta changes shape in response to
endoluminal treatment or progression of disease, the fixed-
length devices can separate. An example is shown in the
Figure. This patient underwent treatment of a TAA, with
subsequent regression of the aneurysm. Aneurysm regres-
Composite sequential computed tomography angiogram reconstru
aneurysm. Regression occurred until 11/01, when a new endo
Additional thoracic endografts were deployed. Six-month follow-usion and increased angulation ultimately led to device sep-
aration, with subsequent endoleak. Additional devices were
used, and the patient continues to undergo regular surveil-
lance.
To help prevent this complication we now preferen-
tially use longer devices (100 mm), when available. In
addition, we have modified our approach from a 20-mm
overlap to as much as half the length of a given device
(50-65 mm). A better approach might be use of a unibody
device of sufficient length to treat the thoracic lesion with a
single device. No such device is yet available.
The observation of these morphologic changes, in ad-
dition to development of endoleaks over time, underscores
the need for continued surveillance. As is the case with
endovascular treatment of AAA, postoperative surveillance
is mandatory to recognize adverse morphologic changes,
and device separation and type I leaks. More recently
patients have been followed up with an endograft surveil-
lance website available through the Lifeline Registry of the
Society for Vascular Surgery/American Association for
Vascular Surgery (http//:www.neri.org/html/research/
clinical/lifeline.asp).
Proximal open-wire configuration of thoracic en-
dografts placed in the thoracic arch have been previously
implicated as contributing to retrograde ascending aortic
dissections in patients with TAA or dissection.16-18 All
patients in this study with this complication were treated
with this device configuration. Although reported in pa-
s demonstrate follow-up of patient treated for descending thoracic
as identified (small arrow) originating from device separation.
02) demonstrated continued regression with absence of endoleak.ction
leak w
p (4/
JOURNAL OF VASCULAR SURGERY
August 2004234 Hansen et altients with TAA and dissection, all 3 patients in this study
had dissections. Although similar in anatomic location, it is
our belief that dissections represent a unique disease pro-
cess that may respond differently to the forces exerted by
certain open-wire stent configurations. For this reason and
on the basis of our clinical experience, we selectively deploy
open-wire stents in the aortic arch in patients with dissec-
tion, and are evaluating other custom-built covered stent
device configurations as part of the investigator IDE.
Paraplegia occurred in 1 patient. This patient under-
went seemingly successful endoluminal exclusion of the
TAA without evidence of complications, but subsequently
had delayed-onset paraplegia despite identification and de-
liberate avoidance of excluding any significant collateral
vessels. Immediately at onset of symptoms a lumbar drain
was placed for CSF decompression, and the hemodynamic
status was optimized. Although the patient improved, he
continues to have weakness in the lower extremities bilat-
erally.5
Our approach to avoiding this complication includes
thorough delineation of large intercostal arteries, especially
in the lower thoracic (T9-T12) distribution. Identification
of these potential collateral vessels is accomplished with the
aid of IVUS imaging in addition to preoperative CT. We do
not cover large intercostal branches, if possible, although
this is occasionally unavoidable. We do not use prophylactic
CSF drainage. However CSF drainage is expeditiously used
in any patient who demonstrates symptoms of spinal isch-
emia post-procedure.
Four patients required exclusion of the left subclavian
artery to obtain adequate proximal neck length. We did not
perform prophylactic left subclavian bypass in these pa-
tients. Our experience and that of others suggests that
prophylactic subclavian bypass in not routinely necessary to
prevent complications related to exclusion of the left sub-
clavian artery.19,20 It should be noted, however, that some
patients, for example, those with a dominant left vertebral
artery, may require bypass to prevent complications. Since
this study we have performed carotid-subclavian bypass for
this very indication.
CONCLUSIONS
Although significant morbidity and mortality remain,
endovascular repair of descending thoracic aneurysms and
dissections in patients at high risk can be accomplished with
acceptable outcomes compared with traditional open re-
pair. Despite the favorability of these findings, complica-
tions unique to endovascular repair of descending thoracic
aortic lesions (eg, device separation) did occur. The major
cause for repeat intervention in these patients was en-
doleak, most commonly caused by device separation.
These complications in part reflect the results of an evolv-
ing technology that involves a requisite learning curve and
developmental issues. Improved understanding and imple-
mentation of this emerging technology in light of these
complications may result in fewer secondary procedures in
these patients, and may lead to reduced morbidity and
mortality. The observed occurrence of endoleaks and con-tinued proximal expansion underscore the need for contin-
ued surveillance.
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